Temasek Holdings (Private) Ltd - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 89 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
Temasek Holdings (Private) Ltd ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$146,828,000
+0.3%
1,240,0000.0%0.58%
-8.6%
Q4 2020$146,456,000
+6.3%
1,240,0000.0%0.63%
-10.1%
Q3 2020$137,814,000
+8.8%
1,240,0000.0%0.70%
-7.4%
Q2 2020$126,703,000
+18.6%
1,240,000
+25.3%
0.76%
-4.1%
Q1 2020$106,851,000
-7.3%
990,0000.0%0.79%
+4.6%
Q4 2019$115,216,000
+1.7%
990,0000.0%0.75%
-9.3%
Q3 2019$113,325,000
+20.1%
990,0000.0%0.83%
+23.1%
Q2 2019$94,347,000
+4.4%
990,0000.0%0.67%
+7.8%
Q1 2019$90,338,000
+20.2%
990,0000.0%0.62%
+20.9%
Q4 2018$75,151,000
-5.1%
990,0000.0%0.52%
+12.1%
Q3 2018$79,200,000
-19.5%
990,0000.0%0.46%
-10.8%
Q2 2018$98,337,000
+22.6%
990,0000.0%0.52%
+17.5%
Q1 2018$80,190,000
+2.8%
990,0000.0%0.44%
-8.1%
Q4 2017$77,982,000
+2184.2%
990,000
+2576.0%
0.48%
+2295.0%
Q3 2017$3,414,00036,9950.02%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2018
NameSharesValueWeighting ↓
Kite Lake Capital Management (UK) LLP 207,382$24,135,00076.46%
Maso Capital Partners Ltd 539,597$62,798,00020.20%
York Capital Management Global Advisors, LLC 1,102,163$128,270,0007.40%
HHLR ADVISORS, LTD. 2,751,200$320,185,0003.99%
Dalton Investments, Inc. 15,551$1,810,0001.14%
Athos Capital Ltd 8,290$965,0000.96%
Myriad Asset Management Ltd. 67,019$7,799,0000.94%
Temasek Holdings (Private) Ltd 990,000$115,216,0000.75%
OXFORD ASSET MANAGEMENT LLP 211,646$24,631,0000.68%
AGF Investments America Inc. 12,230$1,423,0000.47%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders